These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

985 related articles for article (PubMed ID: 30806321)

  • 21. Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results.
    Poddubnyy D; Sieper J; Akar S; Muñoz-Fernández S; Haibel H; Hojnik M; Ganz F; Inman RD
    Rheumatology (Oxford); 2022 Aug; 61(8):3299-3308. PubMed ID: 34897381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-sectional study of patients with axial spondyloarthritis fulfilling imaging arm of ASAS classification criteria: baseline clinical characteristics and subset differences in a single-centre cohort.
    Bubová K; Forejtová Š; Zegzulková K; Gregová M; Hušáková M; Filková M; Hořínková J; Gatterová J; Tomčík M; Szczuková L; Pavelka K; Šenolt L
    BMJ Open; 2019 Apr; 9(4):e024713. PubMed ID: 30944131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
    Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
    Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute anterior uveitis and other extra-articular manifestations of spondyloarthritis.
    Mitulescu TC; Popescu C; Naie A; Predeţeanu D; Popescu V; Alexandrescu C; Voinea LM
    J Med Life; 2015; 8(3):319-25. PubMed ID: 26351533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
    Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
    Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation.
    Corbett M; Soares M; Jhuti G; Rice S; Spackman E; Sideris E; Moe-Byrne T; Fox D; Marzo-Ortega H; Kay L; Woolacott N; Palmer S
    Health Technol Assess; 2016 Feb; 20(9):1-334, v-vi. PubMed ID: 26847392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Associations of Uveitis in Axial Spondyloarthritis Group and Ankylosing Spondylitis Group: Do They Represent the Same Disease?
    Wong OM; Tsang HHL; Chan SCW; Lee KH; Li PH; Lau CS; Chung HY
    J Clin Rheumatol; 2020 Jan; 26(1):1-6. PubMed ID: 30028807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.
    van der Heijde D; Dougados M; Landewé R; Sieper J; Maksymowych WP; Rudwaleit M; Van den Bosch F; Braun J; Mease PJ; Kivitz AJ; Walsh J; Davies O; Bauer L; Hoepken B; Peterson L; Deodhar A
    Rheumatology (Oxford); 2017 Sep; 56(9):1498-1509. PubMed ID: 28498975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is fibromyalgia frequency increasing in axial spondyloarthritis? Association with fibromyalgia and biological therapies.
    Sayın S; Yurdakul FG; Sivas F; Bodur H
    Rheumatol Int; 2020 Nov; 40(11):1835-1841. PubMed ID: 32767083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the clinical characteristics and quality of life of male and female patients with non-radiographic axial spondyloarthritis.
    Unal Enginar A
    Int Immunopharmacol; 2023 Oct; 123():110627. PubMed ID: 37494835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of Assessment of Spondyloarthritis International Society (ASAS) Health Index in Axial Spondyloarthritis and Comparison of ASAS Health Index between Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Data from the Catholic Axial Spondyloarthritis COhort (CASCO).
    Min HK; Lee J; Ju JH; Park SH; Kwok SK
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30959846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Work outcome in yet undiagnosed patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis; results of a cross-sectional study among patients with chronic low back pain.
    van Hoeven L; Boonen AERCH; Hazes JMW; Weel AEAM
    Arthritis Res Ther; 2017 Jun; 19(1):143. PubMed ID: 28623950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis.
    Baraliakos X; Kiltz U; Peters S; Appel H; Dybowski F; Igelmann M; Kalthoff L; Krause D; Menne HJ; Saracbasi-Zender E; Schmitz-Bortz E; Vigneswaran M; Braun J
    Rheumatology (Oxford); 2017 Jan; 56(1):95-102. PubMed ID: 27997346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology practices.
    Kleinert S; Schuch F; Rapp P; Ronneberger M; Wendler J; Sternad P; Popp F; Bartz-Bazzanella P; von der Decken C; Karberg K; Gauler G; Wurth P; Späthling-Mestekemper S; Kuhn C; Vorbrüggen W; Welcker M
    Rheumatol Int; 2024 Apr; 44(4):653-661. PubMed ID: 37805981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Axial Spondyloarthritis - Insights into Upadacitinib.
    Braun J; Kiltz U; Baraliakos X
    Drug Des Devel Ther; 2022; 16():3609-3620. PubMed ID: 36268520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States.
    Zhao SS; Ermann J; Xu C; Lyu H; Tedeschi SK; Liao KP; Yoshida K; Moots RJ; Goodson NJ; Solomon DH
    Rheumatology (Oxford); 2019 Nov; 58(11):2025-2030. PubMed ID: 31081033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis.
    Kilic G; Kilic E; Ozgocmen S
    Medicine (Baltimore); 2014 Dec; 93(29):e337. PubMed ID: 25546683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.
    Deodhar A; Strand V; Kay J; Braun J
    Ann Rheum Dis; 2016 May; 75(5):791-4. PubMed ID: 26768406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
    Burmester GR; Stigler J; Rubbert-Roth A; Tanaka Y; Azevedo VF; Coombs D; Lagunes I; Lippe R; Wung P; Gensler LS
    Rheumatol Ther; 2024 Jun; 11(3):737-753. PubMed ID: 38683479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.